A
Arke Estudios Clinicos S.A. de C.V. | Veracruz, Mexico
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Dulaglutide
LY2189265
Tirzepatide
LY3009104
Ixekizumab
Baricitinib
LY3298176
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 5 total trials
The reason for this study is to see if the study drug called baricitinib works and is safe in children and teenage participants with atopic dermatiti...
Active, not recruiting
Atopic Dermatitis
Drug: Topical corticosteroid
Drug: Baricitinib
This is a study of tirzepatide in participants with overweight and obesity. The main purpose is to learn more about how tirzepatide affects body weig...
Active, not recruiting
Overweight
Obesity
Drug: Placebo
Drug: Tirzepatide
This is designed to assess the long-term safety and efficacy of lebrikizumab for moderate-to-severe atopic dermatitis. It will last up to 33 months.
Active, not recruiting
Atopic Dermatitis
Biological: Lebrikizumab
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems